---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-028604"
form_type: "8-K"
ticker: "ATAI"
cik: "0002081043"
company_name: "AtaiBeckley Inc."
filed_at: "2026-07-16T11:27:30+00:00"
generated_at: "2026-07-16T11:30:09.475914+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# AtaiBeckley to be acquired by Eli Lilly for $6.75/share plus CVRs up to $2.50/share

## Summary
- Merger consideration: $6.75 per share cash plus one CVR per share with potential milestone payments up to $2.50 per share.
- CVR milestones: $1.00 for VLS-01 Phase 3 start, $0.50 for BPL-003 US approval/DEA rescheduling, $1.00 for VLS-01 US approval/DEA rescheduling.
- Termination fee of $104.3M payable by AtaiBeckley under certain conditions; no-shop with fiduciary out.
- Support agreements with directors, officers, and Apeiron Investment Group to vote in favor.
- Conditions include stockholder approval, HSR clearance, no MAE; expected close within 6-9 months.

## SEC filing metadata
- accession: 0001140361-26-028604
- form_type: 8-K
- ticker: ATAI
- cik: 0002081043
- company_name: AtaiBeckley Inc.
- filed_at: 2026-07-16T11:27:30+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2081043/000114036126028604/0001140361-26-028604-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2081043/000114036126028604/ef20078103_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-028604
- JSON: https://secwatch.observer/filing/0001140361-26-028604.json
- Plain text: https://secwatch.observer/filing/0001140361-26-028604.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.